Skip to Content

Resources

Early Decisions, Faster Launch: Optimizing combination Product Commercialization

Article

May 27, 2026

More

Advancing Sterile Liquid Development: Enabling Integrated Solutions for Small Molecules and Biologics

Article

May 21, 2026

More

Optimizing Clinical Trials for the Era of Self-Injectable Combination Products

Article

April 28, 2026

More

Annex 1, Sterility Assurance, and the Rising Bar for PUPSIT

Article

April 24, 2026

More

An integrated path: How CDMOs are reshaping complex drug development

Article

April 22, 2026

More

Extreme Language: “Ultra-High Potency”

Article

April 8, 2026

More

Rare Diseases and the Integrated CDMO Support System. In medicine, rarity is both a curse and a calling. When it comes to rare diseases, some may affect only a handful of families worldwide...

Article

February 26, 2026

More

Packaging as strategy: enabling clinical-to-commercial success for complex therapies. Pharmaceutical packaging is undergoing a fundamental transformation...

Article

February 23, 2026

More

Clinical and Commercial Packaging: Delivering the Next Generation of Pharmaceutical Therapies. As pipelines fill, the role of packaging is expanding well beyond protection and compliance

Article

January 20, 2026

More

Patient-Centric Growth: Navigating the CDMO Inflection Point. CDMOs now rival, and sometimes surpass, pharma sponsors in operational reach and technical breadth.

Article

January 15, 2026

More

Cutting Through Complexity: PCI's Integrated Model for Faster PFS Development. Prefilled syringes (PFS) have rapidly become one of the most influential formats in injectable drug delivery.

Article

January 13, 2026

More

Biopharmaceutical Equipment Maintenance and Risk Mitigation in GMP Manufacturing. Mitigating risk early in the design of manufacturing facilities and the qualification of equipment

Article

January 7, 2026

More